Navigation Links
Aeterna Zentaris Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement
Date:4/27/2010

QUEBEC CITY, April 27 /PRNewswire-FirstCall/ - Aeterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the "Company"), a late-stage drug development company specialized in oncology and endocrinology, announced today that it has received a letter from the Nasdaq Stock Market notifying it that the closing price per share of the Company's common stock was above the US$1.00 minimum bid price for 10 consecutive trading days and that, as a result, the Company has regained compliance with Marketplace Rule 5450(a)(1) (the minimum bid price rule) as of Friday, April 23, 2010.

About Aeterna Zentaris Inc.

Aeterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrine therapy News releases and additional information are available at www.aezsinc.com.


'/>"/>
SOURCE AETERNA ZENTARIS INC.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology news :

1. City of Winter Park Looks to DigitalPersona Software for Stronger Security and CJIS Compliance
2. Pilot study shows effectiveness of new, low-cost method for monitoring hand hygiene compliance
3. NXG Strategies Launches Nations First Website Dedicated to Red Flag Compliance
4. Seabed biodiversity in oxygen minimum zones
5. Minimum information standards -- all for 1 and 1 for all
6. Sinbad Sweets(TM) Offers Select New Desserts at 50% Off Regular Price
7. Winner Medical Group inc. Prices Offering of 1,380,000 Shares of Common Stock
8. New method for recovering pricey nanoparticles
9. Protective footwear for diabetics at a high-street price
10. HIV pays a price for invisibility
11. Tom Cruise smile comes with a sunburn price
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... -- The Allen Institute for Cell Science today announces the ... and dynamic digital window into the human cell. The ... of deep learning to create predictive models of cell ... growing suite of powerful tools. The Allen Cell Explorer ... available resources created and shared by the Allen Institute ...
(Date:4/4/2017)... YORK , April 4, 2017   EyeLock ... today announced that the United States Patent and Trademark ... patent broadly covers the linking of an iris image ... same transaction) and represents the company,s 45 th ... latest patent is very timely given the multi-modal biometric ...
(Date:3/30/2017)... , March 30, 2017 The research ... system for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D ... a new realm of speed and accuracy for use in identification, ... an affordable cost. ... ...
Breaking Biology News(10 mins):
(Date:7/17/2017)... ... 17, 2017 , ... Whitehouse Laboratories is excited to announce ... full series of ISO 80369 standard test procedures. The ISO 80369 series of ... delivery systems. With this recent expansion, Whitehouse Labs becomes one of the only ...
(Date:7/17/2017)... Doylestown, Pa. (PRWEB) , ... ... ... leading provider of technology-enabled clinical trial solutions, today announced safety software company ... channel within the eHealth Solutions business segment to advance technology innovation across ...
(Date:7/17/2017)... ... July 17, 2017 , ... Neurodevelopmental disorders (NDDs) are ... overlapping clinical features. The advancement of targeted next-generation sequencing (NGS) has been instrumental ... testing. , However, designing a custom panel for disease research requires hours ...
(Date:7/17/2017)... ... July 17, 2017 , ... Co-Diagnostics, Inc. (NASDAQ: CODX) ... both to manufacture and sell reagents used for diagnostic tests, has completed its ... in Sandy, Utah, Co-Diagnostics’ intellectual property and technologies are protected by five granted ...
Breaking Biology Technology: